Skip to content

A Clinical trial to study the effects of a unani formulation 'Diabeat'in patients with high blood sugar levels (Type 2 diabetes mellitus )

A clinical study of a herbal formulation 'Diabeat' as an adjuvant drug for the control of type 2 diabetes mellitus

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2009/091/000702
Enrollment
50
Registered
2009-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Diabeat: 2000 mg for 3 months in divided doses Control Intervention1: Placebo: 2000 mg for 3 months in divided doses

Sponsors

Hamdard National Foundation New DElhi
Lead Sponsor
Jamia Hamdard, New Delhi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of type-2 diabetes mellitus, age 30-60 years taking Metformin for more than 3 months with uncontrolled hyperglycaemia i.e.HbA1C between 7% to 9% and Body Mass Index (BMI) between 25-29.9 kg/m2. 2. Patients who are able and willing to follow anti-diabetic therapy under a stable life style and diabetic diet. 3.Patients who are willing and able to understand and follow the protocol and provide informed consent.

Exclusion criteria

Exclusion criteria: 1.History of treatment with any insulin 2.Diabetes mellitus with complications 3.Pregnant or Lactating women 4.Women of childbearing potential who do not take adequate contraceptive protection. 5.History of hypersensitivity to the Metformin or to drug with similar chemical structure. 6.History of any severe systemic disease. 7.Patients with uncontrolled hypertension. 8.History of drug or alcohol abuse.

Design outcomes

Primary

MeasureTime frame
Mean HbA1C 6.5%Timepoint: 12 weeks

Secondary

MeasureTime frame
To achieve a good glycemic control (FPG-80-120 mg/dl; PPG-80-140 mg/dl)Timepoint: 4,8,12 week

Countries

India

Contacts

Public ContactDr Yasmeen Shamsi

Dept. of Moalajat SUMER

yasmeen.ijum@gmail.com26059692

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026